Positron emission tomography in the management of non–small cell lung cancer
- 29 February 2004
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 18 (1) , 269-288
- https://doi.org/10.1016/s0889-8588(03)00152-7
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative reviewThe Lancet Oncology, 2001
- A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancerLung Cancer, 2000
- Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancerEuropean Respiratory Journal, 1999
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Improvement of Non-Small-Cell Lung Cancer Staging by Means of Positron Emission TomographyThe Thoracic and Cardiovascular Surgeon, 1999
- Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Hormonal treatment in advanced non-small cell lung cancer: fact or fiction?European Respiratory Journal, 1996
- Distribution of distant metastases from newly diagnosed non-small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Non-small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosisCancer, 1984
- Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinomaAmerican Journal of Roentgenology, 1982